Literature DB >> 7994322

Valuing future benefits.

J A Cairns1.   

Abstract

This paper reports the results of a study of time preference amongst the general public in the Grampian region of Scotland. The subjects, who were selected randomly from the electoral roll, were offered a series of intertemporal choices. Their responses were used to calculate private financial time preference rates, social non-monetary time preference rates and social financial time preference rates. The paper investigates the relationship between these three measures of time preference in both the short and the long run. It also explores the effects of individual characteristics, including age, and health, on the implicit discount rates.

Mesh:

Year:  1994        PMID: 7994322     DOI: 10.1002/hec.4730030404

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  12 in total

Review 1.  Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies?

Authors:  C Bombardier; A Maetzel
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  Economic notes. Discounting.

Authors:  D J Torgerson; J Raftery
Journal:  BMJ       Date:  1999-10-02

Review 3.  Theoretical arguments for the discounting of health consequences: where do we go from here?

Authors:  Angelina Lazaro
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 4.  Valuing prevention through economic evaluation: some considerations regarding the choice of discount model for health effects with focus on infectious diseases.

Authors:  Jasper M Bos; Philippe Beutels; Lieven Annemans; Maarten J Postma
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

5.  Decision biases in intertemporal choice and choice under uncertainty: testing a common account.

Authors:  Gretchen B Chapman; Bethany J Weber
Journal:  Mem Cognit       Date:  2006-04

6.  Conceptual framework for standard economic evaluation of physical activity programs in primary prevention.

Authors:  Silke B Wolfenstetter
Journal:  Prev Sci       Date:  2011-12

7.  Economics of vaccines revisited.

Authors:  Maarten J Postma; Baudouin A Standaert
Journal:  Hum Vaccin Immunother       Date:  2013-01-30       Impact factor: 3.452

8.  Individual health discount rate in patients with ulcerative colitis.

Authors:  Akbar K Waljee; Arden M Morris; Jennifer F Waljee; Peter D R Higgins
Journal:  Inflamm Bowel Dis       Date:  2010-11-16       Impact factor: 5.325

9.  The economics of primary prevention of cardiovascular disease - a systematic review of economic evaluations.

Authors:  David Lb Schwappach; Till A Boluarte; Marc Suhrcke
Journal:  Cost Eff Resour Alloc       Date:  2007-05-14

10.  The life and health challenges of young Malaysian couples: results from a stakeholder consensus and engagement study to support non-communicable disease prevention.

Authors:  S A Norris; H Anuar; P Matzen; J C H Cheah; B B Jensen; M Hanson
Journal:  BMC Public Health       Date:  2014-06-20       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.